Orange Book product · Generic (ANDA)
DEPO-TESTOSTERONE
TESTOSTERONE CYPIONATE
At a glance
Approved Prior to Jan 1, 1982
Approved
Generic (ANDA)
Application
AO
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
TESTOSTERONE CYPIONATE
Strength
100MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AO
Application
ANDA 085635
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of TESTOSTERONE CYPIONATE
- 2022AZMIROBrand (NDA)
NDA 216318 · AZURITY
- 2023TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 211817 · EUGIA PHARMA
- 2023TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 215351 · XIROMED
- 2019TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 206368 · WILSHIRE PHARMS INC
- 2018TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 210362 · CIPLA
- 2017TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 207742 · AM REGENT
- 2013TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 201720 · SUN PHARM INDS LTD
- 2012TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 091244 · HIKMA FARMACEUTICA
- 2010TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 090387 · HIKMA
- 2006TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 040652 · RISING
- 2006TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 040615 · CAPLIN ONE LABS
- 2005TESTOSTERONE CYPIONATEGeneric (ANDA)
ANDA 040530 · PADAGIS US
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
